DOW INC.

Dow’s search for a buyer for parts of the chlor-alkali and vinyl units in Schkopau was unsuccessful, so the affected plants will be closed as planned by the end of 2027. According to the company, about 160 employees are affected by the partial shutdown; consequences are to be settled through an agreement on interests and a social plan. The Dow site in Böhlen is also affected, where the steamcracker is scheduled for shutdown. The partial closure adds to recent shutdowns by other chemical companies in the Chemiedreieck Sachsen-Anhalt. » Mais em t-online.de

Dow is considering selling its 35% stake in Sadara, the $20 billion joint venture with Saudi Aramco, to reduce a persistent financial drag and improve cash flexibility. As of June 30 Dow had a negative investment balance of $793 million in Sadara and has suspended recognition of its share of the venture's equity losses, while also being exposed to Sadara's financing obligations. Sadara remains a large chemicals complex whose operations were disrupted this year, and selling now could limit future funding needs but risks realising a low valuation amid a weak global chemicals cycle and foregoing potential upside if markets recover. » Mais em finance.yahoo.com

Had $100 been invested in Dow Inc three years ago (price then $53.71), the 1.862 shares would be worth $55.05 at the current closing price of $29.57, a loss of 44.95%. The most recently reported market value of Dow was $21.28 billion. The calculation does not take stock splits and dividends into account. » Mais em finanzen.net

According to Bloomberg, Dow is considering selling its stake in the $20‑billion chemical joint venture Sadara Chemical Co., where it most recently held 35%. The move is part of a portfolio restructuring amid the ongoing downturn in the chemicals industry. Saudi Aramco or other strategic or financial investors could take over the stake, but no decision has been made yet. » Mais em de.investing.com

Dow reported adjusted EPS of $1.44 for Q2 (consensus ~1.25) and revenue of $12.09 billion with operating EBIT of $1.6 billion. The stock is down about 2.8% premarket as investors view the recovery as partly temporary and express concerns about weak demand in Europe and China, excess capacity and volatile raw-material costs. Analyst downgrades and price-target cuts (including Morgan Stanley, Goldman Sachs) as well as doubts about the dividend’s sustainability after a halving earlier this year heighten caution. The negative market environment and the question of whether the geopolitically driven price tailwind will persist lead to a » Mais em de.investing.com